Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation and analgesia weaning in the pediatric intensive care unit
2015-002114-80Phase 2Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in iatrogenic withdrawal syndrome (IWS) and sedation comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Withdrawal Assessment Tool-1 responder rate. Started Jan 2019; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
iatrogenic withdrawal syndrome (IWS)sedation
Beyond the preview
Go deeper on 2015-002114-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002114-80.